Report cover image

Vascular Access Devices Market Report and Forecast 2025-2034

Published Jul 28, 2025
Length 350 Pages
SKU # EMAR20319916

Description

The global vascular access devices market size was valued at USD 4.40 Billion in 2024 , driven by the increasing cases of obesity and diabetes across the globe. The market size is anticipated to grow at a CAGR of 6.50% during the forecast period of 2025-2034 to achieve a value of USD 8.26 Billion by 2034 .

Vascular Access Devices: Introduction

Vascular access devices (VADs) are thin, flexible, tube-like equipment that helps in providing long-term access to blood vessels. VADs are also called PICCs, ports, cannulas, drips, or IVs. Vascular access devices may rescue people with cystic fibrosis who need intravenous (IV) antibiotic treatments regularly, such as during an exacerbation. There are two main categories of vascular access devices: peripherally inserted central catheters (PICC) lines and ports.

Global Vascular Access Devices Market Analysis

The vascular access devices market demand is primarily being driven by the rising development in the market, along with the increasing efforts by the key players. The Teleflex Incorporated, a leading global provider of medical technologies, announced that Premier has awarded them a national agreement for Hemodynamic Monitoring Products and Accessories, a national agreement for Central Venous Access, a Sole Source for AscenDrive Central Venous Access, and a Sole Source for SURPASS Central Venous Access. Teleflex’s accessibility and competitiveness are expected to be influenced positively by this. This endorsement of Teleflex's products through these agreements not only affirms the quality and reliability of their offerings but also makes Teleflex a preferred name in the market, which will directly contribute to the vascular access devices market share.

Both the companies have agreed on some special pricing and terms negotiated by Premier, which will provide added incentives for healthcare providers to choose Teleflex’s solutions, which is expected to potentially influence their purchasing decisions on a broader scale and contribute to Teleflex’s market expansion and the global vascular access devices market growth.

The market demand is also driven by the increased prevalence of chronic diseases such as heart diseases and non-communicable diseases such as depression, hypertension, and obesity among others. The increasing technological advancement of vascular access devices is a major factor driving the market growth.

Global Vascular Access Devices Market Segmentations

Vascular Access Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Device Type
  • Central Vascular Access Devices
  
  • Peripherally Inserted

  •   
  • Central Catheters

  •   
  • Percutaneous Non-tunneled Catheters

  •   
  • Other Central Vascular Access Devices
    • Peripheral Vascular Access Devices
      
  • Peripheral Catheter

  •   
  • Midline Catheter

  •   
  • Other Peripheral Vascular Access Devices
    • Accessories
    Market Breakup by Mode of Insertion
    • Intravenous
    • Subcutaneous
    Market Breakup by Application
    • Administration of Drugs
    • Administration of Fluid and Nutrition
    • Diagnostics and Testing
    • Other Applications
    Market Breakup by End User
    • Hospitals
    • Speciality Clinics
    • Home Healthcare
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Vascular Access Devices Market Overview

    The market growth is driven by the increased prevalence of non-communicable diseases and chronic diseases. These diseases include cancer, tuberculosis, cardiovascular disease, depression, obesity, diabetes, and hypertension, among other conditions. These medical conditions require vascular access procedures for intravenous antibiotic treatment and extraction of blood samples, among others. Due to the increased number of vascular access procedures, the market is expected to draw attention of key players to invest in manufacturing and development of advanced equipment to assist.

    North America has been leading the vascular access devices market demand and is expected to dominate the market during the forecast period as well. According to the data released by the American Cancer Society, more than 1.9 million new cancer cases are expected to occur in the United States in 2023, excluding basal cell and squamous cell skin cancers. Followed by this data, cancer is expected to account for nearly 609,820 deaths in the United States. The data clearly determines that the demand for vascular access devices is expected to increase in the forecast period as a huge population is expected to be diagnosed with cancer, which will result in increased treatment demand for the condition in healthcare facilities, propelling the market growth.

    Global Vascular Access Devices Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Fresenius Medical Care AG & Co.
    • NIPRO Medical Corporation
    • Medtronic
    • AngioDynamics
    • Teleflex Incorporated
    • Vygon SA
    • Terumo Medical Corporation
    • Cardinal Health
    • Abbott
    • Boston Scientific Corporation
    • BIOTRONIK, Inc.
    • Shanghai Puyi Medical Instruments Co, Ltd
    Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Vascular Access Devices Market Overview
    3.1 Global Vascular Access Devices Market Historical Value (2018-2024)
    3.2 Global Vascular Access Devices Market Forecast Value (2025-2034)
    4 Global Vascular Access Devices Market Landscape
    4.1 Global Vascular Access Devices Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Vascular Access Devices Product Landscape
    4.2.1 Analysis by Type
    4.2.2 Analysis by Technology
    4.2.3 Analysis by Application
    5 Global Vascular Access Devices Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Vascular Access Devices Market Segmentation
    6.1 Global Vascular Access Devices Market by Device Type
    6.1.1 Market Overview
    6.1.2 Central Vascular Access Devices
    6.1.2.1 Peripherally Inserted
    6.1.2.2 Central Catheters
    6.1.2.3 Percutaneous Non-tunneled Catheters
    6.1.2.4 Other Central Vascular Access Devices
    6.1.3 Peripheral Vascular Access Devices
    6.1.3.1 Peripheral Catheter
    6.1.3.2 Midline Catheter
    6.1.3.3 Other Peripheral Vascular Access Devices
    6.1.4 Accessories
    6.2 Global Vascular Access Devices Market by Mode of Insertion
    6.2.1 Market Overview
    6.2.2 Intravenous
    6.2.3 Subcutaneous
    6.3 Global Vascular Access Devices Market by Application
    6.3.1 Market Overview
    6.3.2 Administration of Drugs
    6.3.3 Administration of Fluid and Nutrition
    6.3.4 Diagnostics and Testing
    6.3.5 Other Applications
    6.4 Global Vascular Access Devices Market by End User
    6.4.1 Market Overview
    6.4.2 Hospitals
    6.4.3 Speciality Clinics
    6.4.4 Home Healthcare
    6.4.5 Others
    6.5 Global Vascular Access Devices Market by Region
    6.5.1 Market Overview
    6.5.2 North America
    6.5.3 Europe
    6.5.4 Asia Pacific
    6.5.5 Latin America
    6.5.6 Middle East and Africa
    7 North America Vascular Access Devices Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Vascular Access Devices Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Vascular Access Devices Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Vascular Access Devices Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Vascular Access Devices Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 Becton, Dickinson and Company
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisitions
    17.1.5 Certifications
    17.2 Baxter International Inc.
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisitions
    17.2.5 Certifications
    17.3 B. Braun Melsungen AG
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisitions
    17.3.5 Certifications
    17.4 Fresenius Medical Care AG & Co.
    17.4.1 Financial Analysis
    17.4.2 Financial Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisitions
    17.4.5 Certifications
    17.5 NIPRO Medical Corporation
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisitions
    17.5.5 Certifications
    17.6 Medtronic
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisitions
    17.6.5 Certifications
    17.7 AngioDynamics
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisitions
    17.7.5 Certifications
    17.8 Teleflex Incorporated
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisitions
    17.8.5 Certifications
    17.9 Vygon SA
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisitions
    17.9.5 Certifications
    17.10 Terumo Medical Corporation
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisitions
    17.10.5 Certifications
    17.11 Cardinal Health
    17.11.1 Financial Analysis
    17.11.2 Product Portfolio
    17.11.3 Demographic Reach and Achievements
    17.11.4 Mergers and Acquisitions
    17.11.5 Certifications
    17.12 Abbott
    17.12.1 Financial Analysis
    17.12.2 Product Portfolio
    17.12.3 Demographic Reach and Achievements
    17.12.4 Mergers and Acquisitions
    17.12.5 Certifications
    17.13 Boston Scientific Corporation
    17.13.1 Financial Analysis
    17.13.2 Product Portfolio
    17.13.3 Demographic Reach and Achievements
    17.13.4 Mergers and Acquisitions
    17.13.5 Certifications
    17.14 BIOTRONIK, Inc.
    17.14.1 Financial Analysis
    17.14.2 Product Portfolio
    17.14.3 Demographic Reach and Achievements
    17.14.4 Mergers and Acquisitions
    17.14.5 Certifications
    17.15 Shanghai Puyi Medical Instruments Co, Ltd
    17.15.1 Financial Analysis
    17.15.2 Product Portfolio
    17.15.3 Demographic Reach and Achievements
    17.15.4 Mergers and Acquisitions
    17.15.5 Certifications
    18 Global Vascular Access Devices Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket
    How Do Licenses Work?
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.